AIHTA - Publications - Search - Niraparib (Zejula®) in patients with newly diagnosed advanced ovarian cancer. Update February 2021

Grössmann, N. (2021): Niraparib (Zejula®) in patients with newly diagnosed advanced ovarian cancer. Update February 2021. Oncology Fact Sheet Nr. 22.

[thumbnail of Oncology Fact Sheet Nr.22_Update.pdf]
Preview
 PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
91kB

Item Type:Oncology Fact Sheet
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WP Gynaecology > WP 440-468 Uterine diseases
Language:English
Series Name:Oncology Fact Sheet Nr. 22
Deposited on:29 Oct 2020 12:37
Last Modified:01 Feb 2021 18:30

Repository Staff Only: item control page